| mRNA |
Bicalutamide |
GDSC1000 |
pan-cancer |
AAC |
0.0029 |
0.9 |
| mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
-0.0025 |
0.9 |
| mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
0.9 |
| mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0026 |
0.9 |
| mRNA |
AP-24534 |
FIMM |
pan-cancer |
AAC |
-0.012 |
0.9 |
| mRNA |
BYL-719 |
CTRPv2 |
pan-cancer |
AAC |
0.0032 |
0.9 |
| mRNA |
Panobinostat |
CTRPv2 |
pan-cancer |
AAC |
-0.0024 |
0.9 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0023 |
0.9 |
| mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
-0.0023 |
1 |
| mRNA |
Bortezomib |
GDSC1000 |
pan-cancer |
AAC |
-0.0035 |
1 |